News
Straumann Group reports revenue exceeding CHF 2 billion
Einladung: Straumann Group Webcast - Jahresergebnisse 2021
Invitation: Straumann Group 2021 full-year financial results webcast
DGAP-Adhoc: BB Biotech AG mit Verlust im Geschäftsjahr 2021
DGAP-Adhoc: BB Biotech AG closes the 2021 fiscal year with a loss
DGAP-News: BB BIOTECH AG: 2021 war ein schwieriges Jahr für die Biotechaktienmärkte - Erhöhung der Dividende auf CHF 3.85 vorgeschlagen
DGAP-News: BB BIOTECH AG: 2021 was a difficult year for biotech equity markets - increased dividend of CHF 3.85 proposed
Sonova verstärkt Präsenz auf dem US-Markt: Akquisition einer führenden Kette von Hörakustikgeschäften
Sonova to increase presence in US market: Acquisition of leading audiological care network
EQS-Adhoc: Cosmo Pharmaceuticals gibt die Einstellung einer Head of Investor Relations und einen Wechsel im Management-Team bekannt
EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Adhoc: COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A ANNOUNCE SETTLEMENT OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES IN CASSIOPEA S.P.A.
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
EQS-News: Straumann Group präsentiert Weiterentwicklung der Strategie zur Erreichung des langfristigen Umsatzziels von CHF 5 Mrd.
EQS-News: Julie Tay neu zur Wahl in den Sonova Verwaltungsrat nominiert
EQS-News: Sonova nominates Julie Tay for election as a new member of the Board of Directors
EQS-Adhoc: COSMO PHARMACEUTICALS N.V. UND CASSIOPEA S.P.A. VERÖFFENTLICHEN ENDGÜLTIGE ERGEBNISSE DES ÖFFENTLICHEN UMTAUSCHANGEBOTS FÜR ALLE SICH IM PUBLIKUM BEFINDENDEN AKTIEN DER CASSIOPEA S.P.A.
EQS-Adhoc: COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE FINAL RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A.
EQS-News: Straumann Group Capital Markets Day 2021
3 Stocks to Buy for a Soft Landing, If There Is One
Recent economic data is reigniting talk about a soft landing for the economy. That means that the Federal Reserve’s monetary policy regarding interest rates is neither too restrictive nor too
HealthEquity Stock: Leading Health Savings Account Investment
HealthEquity Inc (NASDAQ: HQY) is one of the nation’s largest providers of health savings accounts (HSA) and consumer-directed benefits (CDB) services. Its platform enables individuals to open
Johnson & Johnson is as Cheap as it’s Going to Get
Shares of Johnson & Johnson (NYSE: JNJ) are as cheap as they will get. The stock is down in premarket trading following the Q1 release, but there is a bottom in play and reality to face. Trading
S&P 500's surge to new highs: Bull trap hiding in plain sight?
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) is trading at new highs, but as the sharp pullback on February 13 showed, the rally may be showing signs of cracking.
The market went back into rally
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?
When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back.
Investors